Category Archives: Uncategorized

Weekly Roundup 12-20-13

Posted on December 20, 2013 by Mark Senak

Yes, I did it.  Cards addressed and sent.  Gifts purchased, wrapped and sent.  The snow in my snow globe descends quietly and peacefully conveying my own inner serenity…. And here is a little of what happened this week, as 2013 … Continue reading →

Posted in Uncategorized | Comments Off on Weekly Roundup 12-20-13

Optimizing for Mobile – Do It!

Posted on December 17, 2013 by Mark Senak

Recently a research report by Manhattan Research found that only about a third of pharma web sites have been optimized for mobile use. While I still know people who do not have a smart phone, there aren’t many of them. … Continue reading →

Posted in Uncategorized | Comments Off on Optimizing for Mobile – Do It!

Weekly Roundup – 12-13-13

Posted on December 13, 2013 by Mark Senak

Ho Ho Ho.  Sort of.  Gifts not yet bought, much less wrapped.  In fact, ideas for buying gifts seem not to be forthcoming.  Cards sitting in their boxes without addresses or messages written inside.  Crowded stores.  No parking.  Traffic.  It … Continue reading →

Posted in Uncategorized | Comments Off on Weekly Roundup – 12-13-13

Draft Guidance on Unsolicited Requests for Off-Label Information

Posted on January 5, 2012 by Mark Senak

There has been a good deal of commentary on the recent issuance of a draft guidance by the FDA entitled “Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices” which was issued by the agency on … Continue reading →

Posted in Uncategorized | 4 Comments

DDMAC Enforcement Trickles

Posted on October 4, 2011 by Mark Senak

For some time there has been speculation that enforcement at FDA is up.  But it should be noted that regulatory action letters come from several different parts of the agency and encompass much more than promotional communications. For our purposes, … Continue reading →

Posted in Uncategorized, Warning Letters | 2 Comments